Peptide-Based Topical System Delivers Finasteride for Hair Growth with 40-Fold Less Drug | Research

The takeaway

A carrier-free peptide delivery system applied topically matched or exceeded minoxidil 5% for hair regrowth while using roughly 40 times less finasteride than the standard oral dose.

~40x less drug
Topical peptide-finasteride nanocomplexes matched minoxidil efficacy with dramatically reduced drug exposure

What the researchers found

Peptide-finasteride nanocomplexes promoted hair regeneration comparable to 5% minoxidil in vivo, using approximately 40-fold less finasteride than the standard oral dose.

Why it matters

Finasteride oral side effects limit its use for hair loss. This topical approach could retain efficacy while dramatically reducing systemic drug exposure, potentially making finasteride safer for long-term use.

How the study worked

Preclinical study using cell viability assays, in vivo murine hair regrowth models, and biochemical analysis of follicle cycling.

What this study cannot tell us

Preclinical (mouse model) only; human clinical trials are needed. Differences in human vs. murine hair biology may affect translation.

How to read the evidence

Preclinical study with strong in vivo results in mice, but no human data yet.

When this study was published

Published in 2026.

The bigger picture

This carrier-free peptide platform could be adapted for topical delivery of other drugs beyond hair loss, offering a versatile approach to reducing systemic side effects in dermatology.

Questions still open

Will this formulation show comparable efficacy in human clinical trials?
What is the long-term safety profile of the skin-penetrating peptide itself?
Could this platform deliver other hair loss treatments like dutasteride or minoxidil more effectively?

Common questions

How does this peptide hair treatment work?

A skin-penetrating peptide wraps around finasteride to form tiny nanocomplexes that penetrate the scalp and deliver the drug directly to hair follicles. The peptide itself also reduces inflammation, giving a dual therapeutic effect.

Is this available for hair loss treatment now?

No, this is a preclinical study in mice. Human clinical trials are needed before this could become a commercial product.

Read the original research

Topical Carrier-Free Delivery of Finasteride and Peptides for Enhanced Hair Growth.

Biomacromolecules, 27(2), 1300-1309

View on PubMed ↗Publisher’s paper ↗

Citation

Chung, Won Young; Kim, Ji-Eun; Lee, Jae Yun; Kim, Suin; Jeong, Woo-Jin. (2026). Topical Carrier-Free Delivery of Finasteride and Peptides for Enhanced Hair Growth.. Biomacromolecules, 27(2), 1300-1309. https://doi.org/10.1021/acs.biomac.5c01874